Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Intrinsic Value
Changzhou Qianhong Biopharma Co., Ltd. engages in the research and development, production, and sale of bio-pharmaceutical products. [ Read More ]
The intrinsic value of one Changzhou Qianhong Biopharma Co Ltd stock under the Base Case scenario is 6.62 CNY. Compared to the current market price of 5.34 CNY, Changzhou Qianhong Biopharma Co Ltd is Undervalued by 19%.
Valuation Backtest
Changzhou Qianhong Biopharma Co Ltd
Run backtest to discover the historical profit from buying and selling Changzhou Qianhong Biopharma Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Changzhou Qianhong Biopharma Co Ltd
| Current Assets | 1.5B |
| Cash & Short-Term Investments | 502.8m |
| Receivables | 318.8m |
| Other Current Assets | 707m |
| Non-Current Assets | 1.2B |
| Long-Term Investments | 282.2m |
| PP&E | 562.2m |
| Intangibles | 158.1m |
| Other Non-Current Assets | 207.3m |
| Current Liabilities | 171.2m |
| Accounts Payable | 35.5m |
| Accrued Liabilities | 36.1m |
| Short-Term Debt | 20m |
| Other Current Liabilities | 79.5m |
| Non-Current Liabilities | 99.7m |
| Other Non-Current Liabilities | 99.7m |
Earnings Waterfall
Changzhou Qianhong Biopharma Co Ltd
|
Revenue
|
2.1B
CNY
|
|
Cost of Revenue
|
-1.3B
CNY
|
|
Gross Profit
|
849.3m
CNY
|
|
Operating Expenses
|
-596.5m
CNY
|
|
Operating Income
|
252.8m
CNY
|
|
Other Expenses
|
25.4k
CNY
|
|
Net Income
|
252.9m
CNY
|
Free Cash Flow Analysis
Changzhou Qianhong Biopharma Co Ltd
Profitability Score
Profitability Due Diligence
Changzhou Qianhong Biopharma Co Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Changzhou Qianhong Biopharma Co Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Changzhou Qianhong Biopharma Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Changzhou Qianhong Biopharma Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Changzhou Qianhong Biopharma Co Ltd
According to Wall Street analysts, the average 1-year price target for Changzhou Qianhong Biopharma Co Ltd is 7 CNY .
Shareholder Return
Price
Changzhou Qianhong Biopharma Co Ltd
| Average Annual Return | 15.71% |
| Standard Deviation of Annual Returns | 17.89% |
| Max Drawdown | -49% |
| Market Capitalization | 6.8B CNY |
| Shares Outstanding | 1 274 800 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Changzhou Qianhong Biopharma Co., Ltd. engages in the research and development, production, and sale of bio-pharmaceutical products. The company is headquartered in Changzhou, Jiangsu and currently employs 1,151 full-time employees. The company went IPO on 2011-02-18. The firm mainly provides liquaemin sodium raw materials and preparations, applied to prevent and treat thromboembolism desease; kallidinogen preparations, applied in the treatment of micro-circulation disorder disease, asparaginase bulk drugs and preparations, applied in the treatment of acute lymphoblastic leukemia, as well as compound digestive enzyme capsules II. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Changzhou Qianhong Biopharma Co Ltd stock under the Base Case scenario is 6.62 CNY.
Compared to the current market price of 5.34 CNY, Changzhou Qianhong Biopharma Co Ltd is Undervalued by 19%.
You don't have any saved screeners yet
